Scrip Regulatory Affairs
US FDA to hold workshop on nanomaterial-containing devices
23 August 2010
Vibha Sharma
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Magnifying glass on Sri Lanka on eve of clinical trials bill
- US FDA issues much-awaited draft guidelines on developing biosimilars
- EU adopts a common definition for nanomaterials to provide regulatory clarity
- EMA responds to criticism of reflection paper on non-clinical studies for generic nano-particle iron medicinal product applications
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
